Response assessment to venetoclax in relapsed/refractory chronic lymphocytic leukemia by ultrasonography

Leuk Res. 2021 Jan:100:106488. doi: 10.1016/j.leukres.2020.106488. Epub 2020 Nov 30.

¹ Azienda Ospedaliero-Universitaria Pisana, Department of Clinical and Experimental Medicine, UO Hematology, University of Pisa, Italy. Electronic address: [email protected].
² Azienda Ospedaliero-Universitaria Pisana, Department of Clinical and Experimental Medicine, UO Hematology, University of Pisa, Italy. Electronic address: [email protected].
³ Department of Molecular Biotechnology and Health Sciences, University of Turin, Italy. Electronic address: [email protected].
⁴ Institute of Chemistry of Organometallic Compounds (ICCOM), CNR, Via G Moruzzi 1, 567124, Pisa, Italy. Electronic address: [email protected].
⁵ Strategic Research Program on CLL, Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy. Electronic address: [email protected].
⁶ Strategic Research Program on CLL, Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy. Electronic address: [email protected].
⁷ Section of Statistics, Azienda Ospedaliero-Universitaria Pisana, Italy. Electronic address: [email protected].
⁸ Dipartimento di Tecnologie Sanitarie ESTAR, Azienda Ospedaliero-Universitaria Pisana, Italy. Electronic address: [email protected].
⁹ Azienda Ospedaliero-Universitaria Pisana, Department of Clinical and Experimental Medicine, UO Hematology, University of Pisa, Italy. Electronic address: [email protected].

No abstract available

Publication types